Exosens Shares Drop 4.08% to €57.60, Entering Oversold Territory
Exosens stock fell by 4.08% to €57.60 at midday this Monday, within an SBF 120 that dropped by 0.82% to 6,115.66 points. The specialist in night vision and imaging technologies for defense is among the top 5 biggest losers in the index. The decline intensifies even as the stock still maintains a 65% gain over the year.
Today's movement pushes Exosens below the lower boundary of its Bollinger Bands, set at €60.55. This configuration signals a potential oversold condition, with the price now about 5% below this lower limit. An RSI at 39 confirms selling pressure without reaching the classic oversold zone. The stock is significantly below its 20-day and 50-day moving averages, located at €64.19 and €64.55 respectively, with a gap of more than 10% for each. The 200-day average, at €51.04, remains 12.85% below the price, indicating that the long-term trend is not compromised. The technical support is at €57.50, a level at which the stock is currently trading. The resistance of €67.10 is moving away mechanically.
Tight Valuation Ahead of the General Meeting
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Based on analyst consensus, the stock is trading at about 30.6 times the expected earnings for the current fiscal year and 25.9 times those of the following year, with an estimated earnings per share growth of 18.4% between the two periods. These multiples compare to an industry average of around 18.4 times. The stock market sequence remains heavy after last week's decline, when the stock had dropped below €60 on Friday. As a reminder, the company reported a 19.7% increase in revenue to €122.6 million for the first quarter of 2026, announced on April 29. The next key event on the calendar is the annual general meeting scheduled for May 22, 2026, followed by the semi-annual results on July 28.
Nous avons constaté une forte croissance et une rentabilité.
Exosens continue de bénéficier d'une forte demande pour ses solutions de vision nocturne et d'imagerie numérique.
Risks mentioned
Tensions géopolitiques croissantes pourraient influencer la demande.
Risques liés à l'expansion des capacités de production.
Opportunities identified
Renforcement de la dynamique commerciale dans le marché de la défense.
Recours à des technologies optroniques avancées en pleine expansion.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
